Overview

Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.

Status:
Recruiting
Trial end date:
2022-11-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of CertiroBell® tablet compared with mycophenolate mofetil in primary living donor liver transplant recipients.
Phase:
Phase 4
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Everolimus
Mycophenolic Acid